Bio-Techne (TECH) Income from Continuing Operations (2009 - 2026)
Bio-Techne's quarterly Income from Continuing Operations came in at 51047000.0 in Q1 2026, up 125.99% year-on-year from 22588000.0 in Q1 2025, and up 34.3% quarter-over-quarter from 38009000.0 in Q4 2025.
Bio-Techne has reported Income from Continuing Operations for 18 years, with the latest figure at 51047000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 125.99% year-over-year to 51047000.0; the trailing twelve-month figure through Mar 2026 stood at 22749000.0 (down 71.78% YoY), and the FY2025 full-year result was 13414000.0, down 111.46% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 51047000.0, up from 38009000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 89734000.0 in Q3 2022, with the low at 104492000.0 in Q2 2025.
- Average Income from Continuing Operations over 5 years is 35799352.94, with a median of 45685000.0 recorded in 2023.
- Year-over-year, Income from Continuing Operations surged 193.98% in 2022 and tumbled 899.35% in 2025.
- Tracing TECH's Income from Continuing Operations over 5 years: stood at 50005000.0 in 2022, then plunged by 45.08% to 27465000.0 in 2023, then climbed by 27.03% to 34890000.0 in 2024, then climbed by 8.94% to 38009000.0 in 2025, then surged by 34.3% to 51047000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 51047000.0 (Q1 2026), 38009000.0 (Q4 2025), and 38185000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 51.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.05 Mn |
| Dec 31, 2025 | 38.01 Mn |
| Sep 30, 2025 | 38.19 Mn |
| Jun 30, 2025 | -104.49 Mn |
| Mar 31, 2025 | 22.59 Mn |
| Dec 31, 2024 | 34.89 Mn |
| Sep 30, 2024 | 33.60 Mn |
| Jun 30, 2024 | -10.46 Mn |
| Mar 31, 2024 | 49.06 Mn |
| Dec 31, 2023 | 27.47 Mn |
| Sep 30, 2023 | 50.99 Mn |
| Jun 30, 2023 | 45.69 Mn |
| Mar 31, 2023 | 70.22 Mn |
| Dec 31, 2022 | 50.01 Mn |
| Sep 30, 2022 | 89.73 Mn |
| Jun 30, 2022 | 61.92 Mn |
| Mar 31, 2022 | 60.14 Mn |
| Dec 31, 2021 | 72.06 Mn |
| Sep 30, 2021 | 68.98 Mn |
| Jun 30, 2021 | -65.88 Mn |
| Mar 31, 2021 | 45.40 Mn |
| Dec 31, 2020 | 46.14 Mn |
| Sep 30, 2020 | 33.40 Mn |
| Jun 30, 2020 | 72.45 Mn |
| Mar 31, 2020 | 36.43 Mn |
| Dec 31, 2019 | 119.62 Mn |
| Sep 30, 2019 | 14.40 Mn |
| Jun 30, 2019 | 16.46 Mn |
| Mar 31, 2019 | 44.65 Mn |
| Dec 31, 2018 | 17.56 Mn |
| Sep 30, 2018 | 17.40 Mn |
| Jun 30, 2018 | -39.86 Mn |
| Mar 31, 2018 | 19.74 Mn |
| Dec 31, 2017 | 48.85 Mn |
| Sep 30, 2017 | 15.86 Mn |
| Jun 30, 2017 | 27.61 Mn |
| Mar 31, 2017 | 22.17 Mn |
| Dec 31, 2016 | 7.47 Mn |
| Sep 30, 2016 | 18.84 Mn |
| Jun 30, 2016 | -4.04 Mn |
| Mar 31, 2016 | 30.29 Mn |
| Dec 31, 2015 | 25.85 Mn |
| Sep 30, 2015 | 22.71 Mn |
| Jun 30, 2015 | 29.66 Mn |
| Mar 31, 2015 | 24.29 Mn |
| Dec 31, 2014 | 33.21 Mn |
| Sep 30, 2014 | 23.91 Mn |
| Jun 30, 2014 | -100.86 Mn |
| Mar 31, 2014 | 31.64 Mn |
| Dec 31, 2013 | 25.06 Mn |
| Sep 30, 2013 | 27.43 Mn |
| Jun 30, 2013 | 65.75 Mn |
| Mar 31, 2013 | 33.12 Mn |
| Dec 31, 2012 | 25.36 Mn |
| Sep 30, 2012 | 25.67 Mn |
| Jun 30, 2012 | 27.24 Mn |
| Mar 31, 2012 | 31.76 Mn |
| Dec 31, 2011 | 25.81 Mn |
| Sep 30, 2011 | 27.52 Mn |
| Jun 30, 2011 | -102.75 Mn |
| Mar 31, 2011 | 31.06 Mn |
| Dec 31, 2010 | 26.53 Mn |
| Sep 30, 2010 | 26.37 Mn |
| Jun 30, 2010 | -89.39 Mn |
| Mar 31, 2010 | 32.39 Mn |
| Dec 31, 2009 | 24.72 Mn |
| Sep 30, 2009 | 26.77 Mn |